Stilla Technologies
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Acquired by Bio-Rad in 2025.
Services
Year
2023
Sector
Biotechnology
At the end of 2023, Stilla Technologies launched the Nio™+, a versatile, all-in-one, fit-for-throughput, digital PCR instrument with unparalleled user-friendliness. It is easy to use, fast, and highly automated.
Health tech go-to-market team Ooho was responsible for the marketing strategy behind the launch of this new product. An online webinar was set up so that anyone interested could participate in the live product annuncement. I assisted with editing the teaser video, testimonials, and actual webinar. Credits for the actual footage and concept go to Ooho, Maikel Cozijns and Felix Verhoustraeten. Next to video editing, I also handled several photo shoots to capture their products and create visuals for use on their website.
More projects.
